Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 6, Issue : 4, Year : 2020
Article Page : 554-557
https://doi.org/10.18231/j.ijceo.2020.116
Abstract
Purpose: To study the occurrence of pseudo endophthalmitis among patients undergoing intravitreal avastin (Bevacizumab) under various indications.
Materials and Methods: A retrospective analysis of case records of patients who developed an inflammatory reaction after Intravitreal avastin (Bevacizumab) was done.
Results: Eight of the twenty-Eight patients (28.5%) developed pseudo endophthalmitis. however, the repeated culture of aqueous or vitreous samples did not show any bacterial or fungal growth. all patients showed precipitation of drug in vitreous with the resolution of symptoms after 10 weeks of intensive oral and topical steroid treatment.
Conclusion: Intravitreal avastin (Bevacizumab) can result in pseudo endophthalmitis though it is a diagnosis of exclusion. given many complications, a larger clinical trial of intravitreal avastin (Bevacizumab) is needed to rationalize its use.
Keywords: Avastin (Bevacizumab), Endophthalmitis, Intravitreal, Pseudo.
How to cite : Raj K , Sadiqulla M, Intravitreal injection of avastin (Bevacizumab) from a single vial causing pseudo endophthamitis. Indian J Clin Exp Ophthalmol 2020;6(4):554-557
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.